Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• HSS Study Finds Robotic-Assisted Lumbar Fusion Associated with Significantly Reduced Postoperative Opioid Consumption: Reported by OrthoSpineNews, an 804-patient prospective registry study presented at NASS 2026 demonstrated that robotic arm guidance in MIS-TLIF reduced overall opioid consumption by 16%, first-24-hour opioid requirements by 21%, and intravenous PCA utilization by 57% without increasing complication rates or length of stay.
• Kuros Biosciences Accelerates Commercial Expansion of MagnetOs™ Bone Graft with New U.S. Facility: Reported by OrthoSpineNews, Kuros raised its full-year 2026 guidance following 40% sales growth to $141.8 million, commissioning a new manufacturing facility in Alpharetta, Georgia while advancing three prospective Level I randomized clinical trials across spine and extremity arthrodesis.
• Anatomic Achilles Allograft Reconstruction Demonstrates Reliable Restoration for Chronic Pectoralis Major Tears: Reported by Orthopedics This Week, a surgical technique review in JBJS Essential Surgical Techniques detailed an anatomic Achilles tendon allograft bridging procedure that reliably restores anterior axillary contour, adduction power, and internal rotation torque in retracted chronic tears where native tissue cannot reach the humeral footprint.
• Minuteman® G6 MIS Fusion Plate System Cleared: Spinal Simplicity, LLC received FDA 510(k) clearance (K261607) for the Minuteman® G6 MIS Fusion Plate System indicated for minimally invasive interspinous fixation and sacroiliac joint fusion.
• Alians Forearm Plating System Cleared: Newclip Technics received FDA 510(k) clearance (K262649) for the Alians Forearm Plating System indicated for anatomical plate fixation of diaphyseal and metaphyseal radius and ulna fractures.

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

Hospital for Special Surgery (HSS) — HSS Study Finds Robotic-Assisted Minimally Invasive Lumbar Fusion Associated with Significantly Reduced Postoperative Opioid Consumption

• Summary: In a prospective registry study of 804 patients undergoing one- or two-level minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) presented at the North American Spine Society (NASS 2026) meeting, researchers at Hospital for Special Surgery found that patients treated with robotic arm assistance required 16% less opioid medication overall and 21% less during the initial 24 postoperative hours compared to conventional navigation-guided fusion. Furthermore, robotic-assisted patients were 57% less likely to require intravenous patient-controlled analgesia (PCA), with no observed differences in surgical complication rates or hospital length of stay.
• Key Details:
  • Device/System Name: Robotic Arm-Assisted vs. Navigation-Guided MIS-TLIF Registry Cohort
  • Status: Clinical Evidence Presented at NASS 2026
  • Clinical Significance: Provides multicenter registry evidence demonstrating that robotic arm-assisted spinal guidance delivers clinical recovery benefits extending beyond surgical screw accuracy to measurable reductions in inpatient opioid reliance and patient-controlled analgesia requirements.
• Original Source: OrthoSpineNews

Spine & Orthobiologics

Kuros Biosciences — Kuros Biosciences Accelerates Commercial Expansion of MagnetOs Bone Graft with New U.S. Manufacturing Facility and 40% Sales Growth

• Summary: Kuros Biosciences raised its full-year 2026 financial guidance following a 40% year-over-year increase in medical device sales to $141.8 million through the first nine months, driven by rapid surgical adoption of its MagnetOs bone graft portfolio. The company commissioned its newly constructed manufacturing facility in Alpharetta, Georgia, establishing dual-site production alongside its Bilthoven facility, while advancing three prospective Level I clinical trials across posterolateral lumbar fusion (PROOF reaching 97% enrollment, PRECISE reaching 55%) and hindfoot/ankle arthrodesis (ASTRA reaching 18%).
• Key Details:
  • Device/System Name: MagnetOs™ Bone Graft Portfolio (NeedleGrip™ Surface Technology)
  • Status: Commercial Facility Commissioning & Guidance Upgrade
  • Clinical Significance: Secures scalable domestic manufacturing for submicron surface-engineered osteoinductive synthetic bone grafts while advancing prospective multicenter Level I randomized clinical trials evaluating fusion efficacy against autograft in spine and extremity surgery.
• Original Source: OrthoSpineNews

Trauma & Extremities

Orthopedics This Week — Anatomic Achilles Allograft Reconstruction Demonstrates Reliable Restoration for Chronic, Retracted Pectoralis Major Tendon Tears

• Summary: In a surgical technique review highlighted by Orthopedics This Week and published in JBJS Essential Surgical Techniques, orthopaedic surgeons detailed an anatomic reconstruction technique utilizing Achilles tendon allograft with a calcaneal bone block or soft-tissue weave for chronic, retracted pectoralis major tendon ruptures. In chronic presentations where extensive muscle retraction and scarring preclude direct anatomic fixation to the humeral footprint, Achilles allograft bridging successfully restores anterior axillary contour, adduction power, and internal rotation torque in active patients.
• Key Details:
  • Device/System Name: Achilles Tendon Allograft Reconstruction Technique for Chronic Pectoralis Major Ruptures
  • Status: Peer-Reviewed Surgical Technique & Clinical Appraisal
  • Clinical Significance: Establishes a standardized, reproducible reconstructive strategy for chronic shoulder girdle and chest wall tendon defects, overcoming native tissue deficit to restore humeral mechanical leverage and avoid persistent shoulder dysfunction.
• Original Source: Orthopedics This Week

RECENTLY INDEXED FDA 510(k) & PMA CLEARANCES — ORTHOPAEDIC

Note: The openFDA database typically indexes clearances 2–4 weeks after the official decision date. Dates shown reflect the FDA decision date, not the indexing date.